GCTK
GlucoTrack·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 1
Bearish signal 0
Ample Liquidity
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About GCTK
Glucotrack, Inc.
A medical device and digital health platform company focused on diabetes and prediabetes
Healthcare Equipment and Supplies
05/18/2010
12/10/2021
NASDAQ Stock Exchange
11
12-31
Common stock
301 Route 17 North, Suite 800, Rutherford, NJ 07070
--
GlucoTrack, Inc., was incorporated under the laws of the State of Delaware on May 18, 2010. The Company is a medical device company focused on the design, development and commercialization of new technologies for patients with diabetes and prediabetes. The company is currently developing two products: a non-invasive glucose monitor for patients with type 2 diabetes and prediabetes, and an implantable continuous glucose monitor for patients with type 1 diabetes and insulin-dependent type 2 diabetes.
Company Financials
EPS
GCTK has released its 2025 Q2 earnings. EPS was reported at -9.62, versus the expected 0, missing expectations. The chart below visualizes how GCTK has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
